Achieve Life Sciences, Inc. (ACHV) Social Stream
Achieve Life Sciences Inc (ACHV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACHV.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ACHV's average price target has moved down $11.5 over the prior 44 weeks.
ACHV reports an average of 360.34% for its upside potential over the past 44 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ACHV Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ACHV has a less variance in analysts' estimates than -95.71% of all US stocks.
- ACHV has a higher upside potential (average analyst target price relative to current price) than 194.31% of all US stocks.
- ACHV has a greater average analyst price target than 151.09% of stocks in the small market cap category.
- The number of analysts covering the stock of ACHV is higher than 142.72% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Achieve Life Sciences Inc are SGTX, VYNE and NOVN.
Is ACHV a Buy, Hold or Sell? See the POWR Ratings now!